What is the main business of Impilo?

The main business activity of Impilo focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 20, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Zagórska 73, 42-500 Będzin.

Who is on the management board?

The management board consists of: Damian Kurlej (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $0 in 2024, which is a decrease of 100.0% compared to 2023.

No, the company recorded a net loss of $993 in 2024.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $901 in 2024, representing 100% of all operating expenses.

Impilosp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-11-20

Share capital

5,000.00 PLN

Registered address

ul. Zagórska 73, 42-500 Będzin, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 1 of 6 financial statements was filed late (for 2021, 11 days late).

2025not filed
202402/06/2025
202326/06/2024
202223/06/2023
202126/07/2022
202027/08/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 0.08MedianUSD 1.07mAverageUSD 22.38m

Net profit

This companyUSD -993.43MedianUSD 37.33kAverageUSD 879.18k

Operating costs

This companyUSD 901.03MedianUSD 926.31kAverageUSD 21.06m

Assets

This companyUSD 5.53kMedianUSD 609.81kAverageUSD 11.84m

Industry

Authorized Representatives

Damian Kurlej – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations of will on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Damian Kurlejage 35	10	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2017-05-01 to 2026-07-01.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
AHP Logistykasp. z o.o.	$44,347,030.82	ahop.pl
APS Marcin WalasekS.K.A.	$37,508,581.19	dentaltree.pl
Laerdal Medical Polandsp. z o.o.	$9,110,446.26	laerdal.com
Fortis Pharmaceuticalssp. z o.o.	$6,911,557.57	fortispharmaceuticals.pl
Steriwundsp. z o.o.	$2,832,891.51	steriwund.pl
Farmbudsp. z o.o.	$2,476,637.88	farmbud.eu
Medical Trade Polandsp. z o.o.	$2,257,474.02	meditradepol.com
VMS Medical Simulationsp. z o.o.	$802,411.19	vmsmedical.pl
Madmedsp. z o.o.	$426,323.50	madmed.eu
Ortosilesiasp. z o.o. + limited partnership	$23,684.03	ortosilesia.pl